Entry to the list of donations to the Foundation transparent account

Controling type 2 diabetes

Hyperinsulinemia
0

Hyperinsulinemia

February 14th, 2017 | by Great Britain Association
Hyperinsulinemia is often associated with type 2 diabetes Hyperinsulinemia is often associated with type 2 diabetes, but it isn’t diabetes as such. Hyperinsulinemia means that the amount of insulin in the blood is higher than
Lyxumia (Lixisenatide)
0

Lyxumia (Lixisenatide)

February 13th, 2017 | by admin
Lyxumia is the market name of lixisenatide Lyxumia is a glucagon-like-peptide-1 (GLP-1) agonist that is taken once daily among people with type 2 diabetes. Lyxumia is the market name of lixisenatide and was approved for European
Tresiba (Insulin Degludec)
0

Tresiba (Insulin Degludec)

November 20th, 2015 | by Great Britain Association
Insulin degludec is an ultra long acting basal insulin Insulin degludec, which is supplied under trade name Tresiba, is an ultra long acting basal insulin which can be used by people with type 1 or type 2 diabetes. Tresiba last
Insulin Sensitivity
0

Insulin Sensitivity

November 4th, 2015 | by Great Britain Association
Insulin sensitivity describes how sensitive the body is to the effects of insulin. Someone said to be insulin sensitive will require smaller amounts of insulin to lower blood glucose levels than someone who has low sensitivity.
Starlix (nateglinide)
0

Starlix (nateglinide)

October 30th, 2015 | by h4uclinic
Starlix (nateglinide) is an oral diabetes medicine that helps control blood sugar levels. This medicine helps your body respond better to insulin produced by your pancreas. Starlix is used together with diet and exercise to treat
Prandin (Repaglinide)
0

Prandin (Repaglinide)

October 30th, 2015 | by Great Britain Association
Prandin helps to keep down post meal blood glucose levels Prandin is a drug which is taken before meals and acts quickly to help keep blood glucose levels from rising too high after meals. The drug belongs to a group of diabetes
0

Sulphonylureas

October 25th, 2015 | by Great Britain Association
Sulphonylureas stimulate the production of insulin in the pancreas Sulphonylureas are a class of oral (tablet) medications that control blood sugar levels in patients with type 2 diabetes by stimulating the production of insulin
Forxiga (Dapagliflozin)
0

Forxiga (Dapagliflozin)

October 25th, 2015 | by Great Britain Association
Forxiga works by modifying the role of the kidneys Forxiga is a tablet medication which helps to reduce blood glucose levels by helping the kidneys to remove glucose from the blood and excrete it within urine. The drug helps to
SGLT2 Inhibitors (Gliflozins)
0

SGLT2 Inhibitors (Gliflozins)

October 25th, 2015 | by Great Britain Association
SGLT2 inhibitors help the kidneys lower blood glucose levels Sodium-glucose co-transporter-2 (SGLT2) inhibitors are a new group of oral medications used for treatingtype 2 diabetes. The drugs work by helping the kidneys to lower
Prandial Glucose Regulators (Glinides)
0

Prandial Glucose Regulators (Glinides)

October 25th, 2015 | by Great Britain Association
Prandial glucose regulators stimulate pancreatic beta cells to produce insulin Prandial glucose regulators, also known as glinides, are a family of oral medicines developed for thetreatment of people with type 2 diabetes